Valcyte Poudre pour préparation d'une Solution buvable

Country: Շվեյցարիա

language: ֆրանսերեն

source: Swissmedic (Swiss Agency for Therapeutic Products)

buyitnow

PIL PIL (PIL)
22-05-2024
SPC SPC (SPC)
22-05-2024

active_ingredient:

valganciclovirum

MAH:

CPS Cito Pharma Services GmbH

ATC_code:

J05AB14

INN:

valganciclovirum

pharmaceutical_form:

Poudre pour préparation d'une Solution buvable

composition:

valganciclovirum 5 g ut valgancicloviri hydrochloridum, mannitolum 5.78 g, acidum fumaricum, povidonum K 30, aromatica Tutti Frutti, saccharinum natricum, E 211 100 mg, ad pulverem corresp., solutio reconstituta 50 mg/ml corresp. natrium 16.3 mg.

class:

A

therapeutic_group:

Synthetika

therapeutic_area:

Virostaticum

authorization_status:

zugelassen

authorization_date:

2008-10-29

documents_in_other_languages

PIL PIL իտալերեն 22-05-2024
SPC SPC իտալերեն 22-05-2024